샘플 요청 목록

 카트 문의
시장보고서
상품코드
1888537

세계의 아유르베다 수의약 시장 규모, 점유율, 동향 분석 : 제품별, 동물별, 투여 경로별, 유통 채널별, 지역별, 부문별 예측(2025-2033년)

Ayurveda Veterinary Medicine Market Size, Share & Trends Analysis Report By Product, By Animal, By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

아유르베다 수의약 시장 요약

세계의 아유르베다 수의약 시장 규모는 2024년에 18억 달러로 추정되며, 2033년까지 56억 1,000만 달러에 달할 것으로 예측됩니다.

2025-2033년 연평균 복합 성장률(CAGR) 14.30%를 보일 것으로 예측됩니다. 이러한 시장 성장은 자연친화적이고 전인적인 동물 관리에 대한 선호도 증가, 항균제 내성(AMR)에 대한 우려 증가, 규제 당국의 승인과 정부의 지원적 노력에 힘입어 성장세를 보이고 있습니다.

반려동물 보호자와 축산농가가 화학 동물약품의 잠재적 부작용에 대한 인식이 높아지면서 자연적이고 안전하며 전체론적인 치료법에 대한 관심이 높아지고 있습니다. 웰빙과 허브 요법의 세계 동향은 특히 신흥 경제국에서 동물용 의약품 구매 결정에 영향을 미치고 있습니다. 예를 들어 2025년 6월, Agrovet의 전문가들은 "수의학 아유르베다"를 지속가능한 관찰에 기반한 과학으로 소개하고, 환경 친화적인 솔루션, 인수공통전염병의 위협, 산업적 축산에 대한 피로감에 대한 대응책으로 현대 동물 의료에 통합을 제안했습니다. 이는 합성 화학요법보다 자연에서 유래한 전체론적 동물 웰빙 솔루션에 대한 선호도가 높아지고 있음을 보여줍니다. 이러한 변화로 인해 항생제를 사용하지 않고 동물의 종합적인 건강 증진에 초점을 맞춘 식물 유래 아유르베다 수의학 의약품에 대한 수요가 증가하고 있습니다. 이는 수의사들에 의한 채택을 촉진하고, 허브 기반 수의학 보충제의 소매점 진열대에서의 존재감을 높이고, 면역력 향상제, 스킨케어 제품, 소화 촉진제, 스트레스 관리 솔루션과 같은 새로운 제품 개발을 촉진하고 있습니다.

또한 가축과 반려동물에 대한 항생제 과다 사용은 전 세계에서 항균제 내성(AMR) 증가로 이어져 동물과 인간의 건강에 심각한 위협이 되고 있습니다. 각국 정부, 수의사회, 규제기관은 특히 예방의료와 사료첨가제에서 항생제 사용 감축을 추진하고 있습니다. 예를 들어 2025년 9월에는 축산낙농국(DAHD)이 전국 규모의 가상 교육 프로그램을 개최하여 10만 명의 농가를 대상으로 민족 수의학(EVM)에 대해 특히 아유르베다에 기반한 가축 관리에 대해 중점적으로 설명했습니다. 관계자들은 지속가능한 질병 치료와 항생제 의존도 감소에 있으며, EVM의 역할을 강조했습니다. 이는 AMR에 대한 우려 증가와 맞물려 기존 항생제를 대체할 수 있는 안전한 대안으로 아유르베다 수의학 솔루션에 대한 수요를 강조하고 있습니다. 항염증 작용과 항균 특성으로 알려진 아유르베다 제제는 특히 가금류, 젖소, 반려동물을 돌보는 데 있으며, 천연 대체품으로 사용이 증가하고 있으며, 시장 침투를 가속화하고 허브 기반 동물용 의약품 연구개발에 대한 투자를 늘리고 있습니다.

또한 일부 국가에서는 지원적인 규제 프레임워크, 허브 제품 개발 보조금, 지속가능한 축산 관리에 대한 인센티브를 통해 허브 수의학을 장려하고 있습니다. 인도의 AYUSH부(전통의학부) 등 전통의학 당국은 동물 의료 시스템에 아유르베다의 통합을 적극적으로 추진하고 있습니다. 예를 들어 2024년 10월, 연방 축산부는 항생제 사용을 규제하고 가축 및 가금류 치료에 아유르베다 약물을 공식적으로 통합하여 보다 안전하고 표준화된 치료를 보장하기 위해 새로운 '표준 수의학 치료 지침(SVTG)'을 발표했습니다. 또한 규제 당국의 인증은 소비자의 신뢰를 높이고, 제품 등록을 촉진하며, 아유르베다 동물용 의약품의 새로운 세계 수출 기회를 창출합니다. 이를 통해 투자, 국경 간 파트너십, 허브 기반 동물 건강 브랜드 확장을 위한 유리한 토대를 마련할 수 있습니다. 따라서 현지 제조업체는 사업 규모를 확대하고, 세계 기업의 진입을 촉진하여 상업화의 가속화와 체계적인 성장을 이룰 수 있습니다.

자주 묻는 질문

  • 아유르베다 수의약 시장 규모는 어떻게 예측되나요?
  • 아유르베다 수의약 시장의 성장 요인은 무엇인가요?
  • 아유르베다 수의약의 주요 제품군은 무엇인가요?
  • 아유르베다 수의약 시장에서 반려동물과 생산 동물의 비중은 어떻게 되나요?
  • 아유르베다 수의약 시장의 유통 채널은 어떤 것들이 있나요?
  • 아유르베다 수의약 시장에서 주요 기업은 어디인가요?

목차

제1장 분석 방법·범위

제2장 개요

제3장 시장의 변동 요인·동향·범위

  • 시장 연관 전망
    • 모시장 전망
    • 관련/부수 시장 전망
  • 시장 역학
  • 가격결정 모델의 분석
  • 시장 분석 툴
    • Porter's Five Forces 분석
    • SWOT 분석에 의한 PESTEL

제4장 아유르베다 수의약 시장 : 제품별 추정·동향 분석

  • 아유르베다 수의약 시장 : 제품별 변동 분석
  • 아유르베다 수의약 시장 : 시장 규모 예측과 동향 분석, 제품별(2021-2033년)
  • 의약품
    • 항균제
    • 항염증약
    • 진통제
    • 기타
  • 영양보충제
  • 사료첨가제

제5장 아유르베다 수의약 시장 : 동물별 추정·동향 분석

  • 아유르베다 수의약 시장 : 동물별 변동 분석
  • 아유르베다 수의약 시장 : 시장 규모 예측과 동향 분석, 동물별(2021-2033년)
  • 반려동물
    • 견
    • 묘
    • 마
    • 기타 반려동물
  • 생산 동물
    • 우
    • 가금
    • 돈
    • 기타 생산 동물

제6장 아유르베다 수의약 시장 : 투여 경로별 추정·동향 분석

  • 아유르베다 수의약 시장 : 투여 경로별 변동 분석
  • 아유르베다 수의약 시장 : 시장 규모 예측과 동향 분석, 투여 경로별(2021-2033년)
  • 경구
  • 국소
  • 기타

제7장 아유르베다 수의약 시장 : 유통 채널별 추정·동향 분석

  • 아유르베다 수의약 시장 : 유통 채널별 변동 분석
  • 아유르베다 수의약 시장 : 시장 규모 예측과 동향 분석, 유통 채널별(2021-2033년)
  • 동물병원/진료소 부속 약국
  • 소매점/전문점
  • E-Commerce
  • 기타

제8장 아유르베다 수의약 시장 : 지역별 추정·동향 분석

  • 시장 대시보드 : 지역별
  • 시장 점유율 분석 : 지역별(2024년·2033년)
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 덴마크
    • 스웨덴
    • 노르웨이
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 호주
    • 태국
    • 한국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 남아프리카공화국
    • 아랍에미리트
    • 사우디아라비아
    • 쿠웨이트
    • 카타르
    • 오만

제9장 경쟁 구도

  • 시장 참여 기업의 분류
    • 시장 리더
    • 신규 기업
  • 시장 점유율/평가 분석(히트맵 분석, 2024년)
  • 기업 개요
    • Himalaya Wellness Company
    • AYURSUN PHARMA
    • Vetraise Remedies
    • Garuda Trade Kft.
    • Zenex Health Animal Health
    • Bioved
    • Curafyt
    • Euro Herbals
    • SaluVet GmbH
    • Natural Remedies
    • Shelter Pharma
    • Indian Herbs
KSA

Ayurveda Veterinary Medicine Market Summary

The global Ayurveda veterinary medicine market size was estimated at USD 1.80 billion in 2024 and is projected to reach USD 5.61 billion by 2033, growing at a CAGR of 14.30% from 2025 to 2033. The market growth is driven by rising preference for natural and holistic animal care, increasing concerns over antimicrobial resistance (AMR) and supportive regulatory approvals and government initiatives.

Growing awareness among pet owners and livestock farmers about the potential side effects of chemical-based veterinary drugs is creating a strong inclination toward natural, safe, and holistic treatments. Global trends in wellness and herbal therapy are influencing animal healthcare purchasing decisions, especially in emerging economies. For instance, in June 2025, experts of Agrovet highlighted Veterinary Ayurveda as a sustainable, observation-based science offering eco-friendly solutions, zoonotic threats, and industrial farming fatigue, advocating its integration in modern animal healthcare. This demonstrated increasing preference for nature-derived, holistic animal wellness solutions over synthetic chemical treatments. This shift encourages higher demand for Ayurveda veterinary medicines that are plant-based, free from antibiotics, and focus on overall animal wellness. It boosts adoption among veterinarians, increases retail shelf presence of herbal veterinary supplements, and drives new product development for immunity boosters, skin care, digestion enhancers, and stress management solutions.

In addition, excessive use of antibiotics in livestock and pets has led to a global rise in antimicrobial resistance (AMR), which poses a major threat to both animal and human health. Governments, veterinary associations, and regulatory bodies are promoting reductions in antibiotic usage, especially in preventive care and feed supplements. For instance, in September 2025, Department of Animal Husbandry and Dairying (DAHD) hosted a nationwide virtual awareness program on Ethno Veterinary Medicine (EVM), emphasizing Ayurveda-based livestock care to one lakh farmers. Officials highlighted EVM's role in treating diseases sustainably and reducing antibiotic dependence. This aligns with growing concerns over AMR, emphasizing the demand for Ayurveda veterinary solutions as safer alternatives to conventional antibiotics. Ayurvedic formulations, which are known for their anti-inflammatory and antimicrobial properties, are increasingly used as natural substitutes, particularly in poultry, dairy, and companion animal care, thus accelerating market penetration and increasing investments in herbal veterinary R&D.

Furthermore, some of the countries are promoting herbal veterinary healthcare through supportive regulatory frameworks, subsidies for herbal product development, and incentives for sustainable livestock management. Traditional medicine authorities, such as India's AYUSH Ministry, are actively encouraging Ayurvedic integration in veterinary healthcare systems. For instance, in October 2024, Union Ministry of Animal Husbandry released new Standard Veterinary Treatment Guidelines (SVTG) to regulate antibiotic usage and formally integrate Ayurvedic drugs for livestock and poultry treatment, ensuring safer, standardized care. In addition, regulatory validation increases consumer trust, accelerates product registrations, and opens new global export opportunities for Ayurveda veterinary products. This creates a favorable platform for investments, cross-border partnerships, and expansion of herbal animal health brands. Hence, local manufacturers scale operations for global players to enter space, for accelerated commercialization and structured growth.

Global Ayurveda Veterinary Medicine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Ayurveda veterinary medicine market report based on product, animal, route of administration, distribution channel, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceuticals
    • Antimicrobial
    • Anti-inflammatory
    • Analgesics
    • Others
  • Nutritional Supplements
  • Feed Additives
  • Animal Outlook (Revenue, USD Million, 2021 - 2033)
  • Companion Animals
    • Dogs
    • Cats
    • Horses
    • Other Companion Animals
  • Production Animals
    • Cattle
    • Poultry
    • Swine
    • Other Production Animals
  • Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
  • Oral
  • Topical
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Veterinary Hospitals/Clinic Pharmacies
  • Retail/Specialty Stores
  • E-Commerce
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Animal
    • 1.2.3. Route of Administration
    • 1.2.4. Distribution Channel
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information/Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Model 1: Commodity Flow Analysis
    • 1.7.2. Model 2: Bottom-Up Analysis
    • 1.7.3. Model 3 Volume-Pricing Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary/Related Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Preference for Natural and Holistic Animal Care
      • 3.2.1.2. Increasing Concerns Over Antimicrobial Resistance (AMR)
      • 3.2.1.3. Supportive Regulatory Approvals and Government Initiatives
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Limited Scientific Validation and Clinical Evidence
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Pricing Model Analysis
  • 3.4. Market Analysis Tools
    • 3.4.1. Porter's Five Forces Analysis
    • 3.4.2. PESTEL by SWOT Analysis

Chapter 4. Ayurveda Veterinary Medicine Market: Product Estimates & Trend Analysis

  • 4.1. Ayurveda Veterinary Medicine Market, By Product: Segment Dashboard
  • 4.2. Ayurveda Veterinary Medicine Market, By Product Movement Analysis
  • 4.3. Ayurveda Veterinary Medicine Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
  • 4.4. Pharmaceuticals
    • 4.4.1. Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033(USD Million)
    • 4.4.2. Antimicrobial
      • 4.4.2.1. Antimicrobial Market Estimates and Forecasts, 2021 - 2033(USD Million)
    • 4.4.3. Anti-inflammatory
      • 4.4.3.1. Anti-inflammatory Market Estimates and Forecasts, 2021 - 2033(USD Million)
    • 4.4.4. Analgesics
      • 4.4.4.1. Analgesics Market Estimates and Forecasts, 2021 - 2033(USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 4.5. Nutritional Supplements
    • 4.5.1. Nutritional Supplements Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 4.6. Feed Additives
    • 4.6.1. Feed Additives Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 5. Ayurveda Veterinary Medicine Market: By Animal Estimates & Trend Analysis

  • 5.1. Ayurveda Veterinary Medicine Market, By Animal: Segment Dashboard
  • 5.2. Ayurveda Veterinary Medicine Market, By Animal Movement Analysis
  • 5.3. Ayurveda Veterinary Medicine Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
  • 5.4. Companion Animals
    • 5.4.1. Companion Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.2. Dogs
      • 5.4.2.1. Dogs Market Estimates and Forecasts, 2021 - 2033(USD Million)
    • 5.4.3. Cats
      • 5.4.3.1. Cats Market Estimates and Forecasts, 2021 - 2033(USD Million)
    • 5.4.4. Horses
      • 5.4.4.1. Horses Market Estimates and Forecasts, 2021 - 2033(USD Million)
    • 5.4.5. Other Companion Animals
      • 5.4.5.1. Other Companion Animals Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 5.5. Production Animals
    • 5.5.1. Production Animals Market Estimates and Forecasts, 2021 - 2033(USD Million)
    • 5.5.2. Cattle
      • 5.5.2.1. Cattle Market Estimates and Forecasts, 2021 - 2033(USD Million)
    • 5.5.3. Poultry
      • 5.5.3.1. Poultry Market Estimates and Forecasts, 2021 - 2033(USD Million)
    • 5.5.4. Swine
      • 5.5.4.1. Swine Market Estimates and Forecasts, 2021 - 2033(USD Million)
    • 5.5.5. Other Production Animals
      • 5.5.5.1. Other Production Animals Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 6. Ayurveda Veterinary Medicine Market: By Route of Administration Estimates & Trend Analysis

  • 6.1. Ayurveda Veterinary Medicine Market, By Route of Administration: Segment Dashboard
  • 6.2. Ayurveda Veterinary Medicine Market, By Route of Administration Movement Analysis
  • 6.3. Ayurveda Veterinary Medicine Market Estimates & Forecasts, by Route of Administration, 2021 to 2033 (USD Million)
  • 6.4. Oral
    • 6.4.1. Oral Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 6.5. Topical
    • 6.5.1. Topical Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 7. Ayurveda Veterinary Medicine Market: By Distribution Channel Estimates & Trend Analysis

  • 7.1. Ayurveda Veterinary Medicine Market, By Distribution Channel: Segment Dashboard
  • 7.2. Ayurveda Veterinary Medicine Market, By Distribution Channel Movement Analysis
  • 7.3. Ayurveda Veterinary Medicine Market Estimates & Forecasts, by Distribution Channel, 2021 to 2033 (USD Million)
  • 7.4. Veterinary Hospitals/Clinic Pharmacies
    • 7.4.1. Veterinary Hospitals/Clinic Pharmacies Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 7.5. Retail/Specialty Stores
    • 7.5.1. Retail/Specialty Stores Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 7.6. E-Commerce
    • 7.6.1. E-Commerce Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 7.7. Others
    • 7.7.1. Others Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 8. Ayurveda Veterinary Medicine Market: By Regional Estimates & Trend Analysis

  • 8.1. Region Market Dashboard
  • 8.2. Region Market Share Analysis, 2024 & 2033
  • 8.3. North America
    • 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. South Korea
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. Saudi Arabia
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.6. Qatar
      • 8.7.6.1. Key Country Dynamics
      • 8.7.6.2. Competitive Scenario
      • 8.7.6.3. Regulatory Framework
      • 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.7. Oman
      • 8.7.7.1. Key Country Dynamics
      • 8.7.7.2. Competitive Scenario
      • 8.7.7.3. Regulatory Framework
      • 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
  • 9.3. Company Profiles
    • 9.3.1. Himalaya Wellness Company
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product/Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. AYURSUN PHARMA
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product/Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Vetraise Remedies
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product/Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Garuda Trade Kft.
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product/Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Zenex Health Animal Health
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product/Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Bioved
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product/Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Curafyt
      • 9.3.7.1. Participant's Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product/Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Euro Herbals
      • 9.3.8.1. Participant's Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product/Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. SaluVet GmbH
      • 9.3.9.1. Participant's Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product/Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Natural Remedies
      • 9.3.10.1. Participant's Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product/Service Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Shelter Pharma
      • 9.3.11.1. Participant's Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Product/Service Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. Indian Herbs
      • 9.3.12.1. Participant's Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Product/Service Benchmarking
      • 9.3.12.4. Strategic Initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제